MedTrace Logo

Silicosis Treatment, Action, Screening and Surveillance in Rwanda Trials

NCT05538299 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 995

Last updated 2022-09-22

No results posted yet for this study

Summary

Silicosis is the most prevalent occupational lung disease in low- and middle-income countries (LMICs) with "tens of millions" estimated to suffer from the disease according to the World Health Organization (WHO). To date, there is little published data on silicosis in LMICs and the burden of silicosis in Rwanda has not been well-defined. Silicosis among local mine workers is a common reason for hospitalization and death at Rwinkwavu District Hospital, located in Rwanda's Kayonza District.

The objectives of this study are:

1. To assess the prevalence of silicosis among workers in four mines located in the Kayonza District of Rwanda
2. To adapt a validated screening tool testing in Dutch construction workers for Rwandan miners
3. To implement an occupational health education program and assess the change of before and after intervention that target towards proper use of PPE and individual risk assessment in mine workers using knowledge-attitudes-practice tool

Conditions

  • Silicosis
  • Silicotic Fibrosis (Massive) of Lung

Interventions

BEHAVIORAL

questionnaire, KAP

Diagnostic studies including questionaire, CXR, spirometry, clinical assesment, occupational safety training

Sponsors & Collaborators

  • Samuel Hatfield

    lead OTHER

Principal Investigators

  • Innocent Kamali · Partners in Health

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2022-12-31
Completion
2023-07-31

Countries

  • Rwanda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05538299 on ClinicalTrials.gov